With $12 million in funding, the company is building artificial intelligence software, diagnostic tests and partnerships with pharma companies to match patients with the best treatments.
Covid-19 is spreading rapidly through the Sunbelt. Will it be as deadly for older adults living in long-term care facilities as it was in April and May?
Walgreens Boots Alliance suffered a negative impact of $700 million to $750 million as the company sustained a major loss of global business from the surge of cases of the coronavirus strain Covid-19 that caused its customers to shelter in their homes.
Dr. Stephen Thomas, Chief of Infectious Diseases at SUNY Upstate Medical University, discusses his experience volunteering for a malaria vaccine trial in 2001 and how to evaluate the risks of human challenge experiments in search of a coronavirus vaccine.
Hospital design experts Ryan Hullinger and Sarah Markovitz explain the design changes to help healthcare facilities reduce stress for workers during the Covid-19 pandemic and beyond.
Covid-19 is shaking up how patients and insurers alike view telemedicine. Tech-enabled pharmacy startup raised $25 million from Optum Ventures and others to take advantage of that shift.
Walgreens will invest $1 billion in VillageMD to open ‘500 to 700’ physician-staffed clinics inside its drugstores in more than 30 U.S. markets within the next five years.
While many businesses are suffering during the recession caused by the coronavirus pandemic, telemedicine companies, including Doctor on Demand, are doing better than ever.